DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs

J Yu, T Xie, Z Wang, X Wang, S Zeng, Y Kang… - Drug Discovery …, 2019 - Elsevier
Highlights•The structure-related regulatory mechanisms of active DNMTs are outlined.•The
therapeutic importance of DNMTs in different cancer types is briefly compared.•The most …

DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application

C Hu, X Liu, Y Zeng, J Liu, F Wu - Clinical Epigenetics, 2021 - Springer
DNA methylation, an epigenetic modification, regulates gene transcription and maintains
genome stability. DNA methyltransferase (DNMT) inhibitors can activate silenced genes at …

DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies

J Fahy, A Jeltsch, PB Arimondo - Expert opinion on therapeutic …, 2012 - Taylor & Francis
Introduction: DNA methylation is an epigenetic modification that modulates gene expression
without altering the DNA base sequence. It plays a crucial role in cancer by silencing tumor …

Epigenetic control of gene expression: Potential implications for cancer treatment

F Perri, F Longo, M Giuliano, F Sabbatino… - Critical reviews in …, 2017 - Elsevier
Epigenetic changes are defined as inherited modifications that are not present in DNA
sequence. Gene expression is regulated at various levels and not only in response to DNA …

DNA demethylation and cancer: therapeutic implications

M Szyf, P Pakneshan, SA Rabbani - Cancer letters, 2004 - Elsevier
The epigenome, which is comprised of chromatin and its associated proteins and the
patterns of covalent modification of DNA by methylation, sets up and maintains gene …

Epigenetic cancer therapy: Proof of concept and remaining challenges

C Mund, F Lyko - Bioessays, 2010 - Wiley Online Library
Over the past few years several drugs that target epigenetic modifications have shown
clinical benefits, thus seemingly validating epigenetic cancer therapy. More recently …

Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy

H Gowher, A Jeltsch - Cancer biology & therapy, 2004 - Taylor & Francis
Hypermethylation of tumor suppressor genes caused by aberrant activity of DNA
methyltransferases is an important mechanism that contributes to cancer. The reaction …

[HTML][HTML] DNA methylation, its mediators and genome integrity

H Meng, Y Cao, J Qin, X Song, Q Zhang… - … journal of biological …, 2015 - ncbi.nlm.nih.gov
DNA methylation regulates many cellular processes, including embryonic development,
transcription, chromatin structure, X-chromosome inactivation, genomic imprinting and …

Epigenetic cancer therapy: rationales, targets and drugs

M Rius, F Lyko - Oncogene, 2012 - nature.com
The fundamental role of altered epigenetic modification patterns in tumorigenesis
establishes epigenetic regulatory enzymes as important targets for cancer therapy. Over the …

[PDF][PDF] DNA methylation inhibitors in cancer therapy: the immunity dimension

JD Licht - Cell, 2015 - cell.com
DNA demethylating agents are approved for some blood malignancies and are under active
investigation in solid tumors, but how these drugs work has remained unclear. In this issue …